Title:
二特異性結合分子
Document Type and Number:
Japanese Patent JP2023513706
Kind Code:
A
Abstract:
本開示は、ヒトサバイビン及びヒトＣＤ３に結合する、新規の二特異性分子並びにこれを作る方法及びこれを使用する方法を提示する。
Inventors:
Shervin, Adam Es
Don, Fen
Riley, edward bee
Stone, Jennifer Dee
White, Michael Kay
Don, Fen
Riley, edward bee
Stone, Jennifer Dee
White, Michael Kay
Application Number:
JP2022548668A
Publication Date:
April 03, 2023
Filing Date:
February 11, 2021
Export Citation:
Assignee:
AbbVie Incorporated
International Classes:
C07K19/00; C07K14/725; C07K16/28; C07K16/46; C12N15/12; C12N15/13; C12N15/62
Attorney, Agent or Firm:
Kawaguchi International Patent Office
Previous Patent: Method for recovering active metal of lithium secondary battery
Next Patent: Using General Constraint Flags in Video Bitstreams
Next Patent: Using General Constraint Flags in Video Bitstreams